---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-117666"
form_type: "8-K"
ticker: "TLSI"
cik: "0001826667"
company_name: "TriSalus Life Sciences, Inc."
filed_at: "2022-11-14T23:59:59+00:00"
generated_at: "2026-06-21T21:05:47.142039+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# MedTech Acquisition Corp. to merge with TriSalus Life Sciences for $220M in stock

## Summary
- Merger consideration: $220M paid entirely in MTAC common stock valued at $10.00 per share.
- Closing conditions include MTAC having at least $60M in available cash and net tangible assets ≥$5M.
- Sponsor agrees to forfeit 2,187,500 shares and subject 3,125,000 shares to vesting restrictions.
- Non-binding term sheet for up to $50M of 8.0% senior secured convertible notes from Magnetar Capital.
- TriSalus stockholders subject to 365-day lock-up; lock-up ends earlier if stock hits $12 for 20 of 30 days after 150 days.

## SEC filing metadata
- accession: 0001104659-22-117666
- form_type: 8-K
- ticker: TLSI
- cik: 0001826667
- company_name: TriSalus Life Sciences, Inc.
- filed_at: 2022-11-14T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826667/000110465922117666/0001104659-22-117666-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826667/000110465922117666/tm2230343d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-117666
- JSON: https://secwatch.observer/filing/0001104659-22-117666.json
- Plain text: https://secwatch.observer/filing/0001104659-22-117666.txt

## Key facts
- Material Agreements
  TriSalus Life Sciences, Inc. entered into Agreement and Plan of Merger with MedTech Acquisition Corporation and MTAC Merger Sub, Inc. valued at $220,000,000 (effective 2022-11-11).
  - Action: entry
  - Agreement: merger
  - Counterparty: MedTech Acquisition Corporation and MTAC Merger Sub, Inc.
  - Value: $220,000,000
  - Effective: 2022-11-11
  source text: On November 11, 2022, MedTech Acquisition Corporation, a Delaware corporation (" MTAC "), entered into an Agreement and Plan of Merger (the " Merger Agreement ") with MTAC Merger Sub, Inc., a Delaware corporation and direct, wholly owned subsidiary of MTAC (" Merger Sub "), and TriSalus Life Sciences, Inc., a Delaware corporation (" TriSalus ")
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465922117666/0001104659-22-117666-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.